LITTLE FALLS, N.J., May 30, 2014 /PRNewswire/ -- CANTEL MEDICAL CORP. (CMN) will release the results for its third quarter ended April 30, 2014 on Thursday, June 5 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET. Participating in the call will be Charles M. Diker, Chairman; Andrew A. Krakauer, President and CEO; Jorgen B. Hansen, Executive Vice President and COO; Craig A. Sheldon, Senior Vice President, CFO and Treasurer; and Seth Yellin, Senior Vice President-Corporate Development.
To participate in the conference call, dial (877) 407-8033 approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Thursday, June 5, 2014 through midnight on August 5, 2014 by dialing (877) 660-6853 and using conference ID # 13583774.
The call will be simultaneously broadcast live over the Internet on vcall.com at http://www.investorcalendar.com/IC/CEPage.asp?ID=172835. A replay of the webcast will be available for 90 days on PrecisionIR and via the investor relations page of the Cantel web site.
About Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
- Health Care Industry
- Investment & Company Information
- Executive Vice President